U.S. Markets closed

UnitedHealth Group Incorporated (UNH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
351.30+0.77 (+0.22%)
At close: 4:00PM EST

351.30 -0.10 (-0.03%)
After hours: 5:03PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close350.53
Open349.12
Bid347.29 x 800
Ask351.68 x 800
Day's Range345.74 - 353.05
52 Week Range187.72 - 367.95
Volume3,616,855
Avg. Volume3,191,965
Market Cap333.321B
Beta (5Y Monthly)0.74
PE Ratio (TTM)20.18
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield5.00 (1.43%)
Ex-Dividend DateDec 04, 2020
1y Target EstN/A
  • UnitedHealth (UNH) Enhances Virtual Care for Better Outcomes
    Zacks

    UnitedHealth (UNH) Enhances Virtual Care for Better Outcomes

    UnitedHealth (UNH) introduces virtual care offerings and expands services to boost telehealth visits.

  • Billionaire Stephen Mandel’s Lone Pine Is Embracing The Tech Revolution
    Insider Monkey

    Billionaire Stephen Mandel’s Lone Pine Is Embracing The Tech Revolution

    In this article, we reviewed returns from billionaire Stephen Mandel’s top ten stock picks to determine whether Lone Pine’s strategy of embracing the tech revolution is working. Click to skip ahead and see Billionaire Stephen Mandel’s Top 5 Stock Picks. Julian Robertson’s protege Stephen Mandel’s hedge fund Lone Pine Capital has generated annualized returns of […]

  • Moody's

    Team Health Holdings, Inc. -- Moody's announces completion of a periodic review of ratings of Team Health Holdings, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Team Health Holdings, Inc. New York, January 14, 2021 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Team Health Holdings, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review discussion held on 11 January 2021 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.